ARCHIVES

Government Offers Two Approval Standards For Assays: CLIA, FDA

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011

In Brief: Shingleton To Head AACI; Saunders To Get Two More Jobs At U. Texas Medical Branch

January 21, 1977

DePinho Seeks Broad Waiver From COI Policy To Cover Financial Ties With 12 Entities

September 21, 2012

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006